American Healthcare REIT, Inc. (AHR) - Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. American Healthcare REIT, Inc. is a self-managed REIT operating a diversified portfolio of clinical healthcare real estate, including integrated senior health campuses, outpatient medical (OM) buildings, senior housing operating properties (SHOP), and triple-net leased properties. As of March 31, 2025, the company owned or operated 312 buildings and campuses representing approximately 19.0 million square feet of gross leasable area.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Total Revenues | $540.6 million | $499.5 million |
| Net Loss (GAAP) | $(6.8) million | $(3.0) million |
| Net Loss Per Share (Diluted) | $(0.04) | $(0.04) |
| Net Operating Income (NOI) | $94.5 million | $82.2 million |
| Funds from Operations (FFO) | $55.9 million | $31.3 million |
| Normalized FFO | $59.7 million | $31.1 million |
| Cash from Operating Activities | $60.6 million | $(6.0) million |
| Total Debt Outstanding | $1.666 billion | $2.011 billion |
| Cash and Cash Equivalents | $86.1 million | $77.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 8.2% year-over-year, driven by a 10.0% increase in resident fees and services revenue due to higher occupancy and billing rates in the Integrated Senior Health Campuses and SHOP segments.
- Impairment Charge: The company recognized a non-cash impairment charge of $21.7 million related to one OM building, compared to no impairment in Q1 2024. This significantly impacted GAAP net loss.
- Interest Expense Reduction: Total interest expense decreased to $23.7 million from $30.0 million in the prior year, primarily due to debt paydowns using proceeds from 2024 equity offerings.
- Operating Cash Flow: Net cash provided by operating activities improved significantly to $60.6 million from a use of $6.0 million in Q1 2024, reflecting improved property performance and lower interest payments.
- Debt Reduction: Total debt decreased by approximately $345 million year-over-year. The company terminated the Trilogy Credit Facility in March 2025, repaying all borrowings.
Guidance, Outlook, and Risks
- Outlook: Management expects continued inflationary pressures on labor and services but anticipates offsetting these through rent and care fee increases. The company maintains a quarterly distribution of $0.25 per share.
- Liquidity: As of March 31, 2025, the company had $507 million available under its $1.15 billion 2024 Credit Facility. Management believes current liquidity sources are sufficient for the next 12 months.
- Risks:
- Interest Rate Risk: The company has variable-rate debt exposure, though it utilizes interest rate swaps to mitigate risk. A 0.50% increase in rates would increase annualized interest expense by approximately $0.47 million.
- Regulatory & AI Risks: New risk factors include potential legislative changes limiting REIT investment in healthcare and risks associated with the use of Artificial Intelligence (AI) by the company, vendors, or tenants, including data privacy and cybersecurity threats.
- Geographic Concentration: Properties in Indiana, Ohio, and Michigan accounted for 46.8%, 13.1%, and 11.5% respectively of the portfolio's annualized base rent/NOI.
Investor Verification Checklist
- Impairment Details: Verify the specific operational metrics and fair value assessment of the OM building that triggered the $21.7 million impairment charge.
- Debt Maturity Profile: Review the maturity schedule for the $1.02 billion in fixed-rate mortgage loans and the $643 million in variable-rate credit facility debt to assess refinancing risks.
- Occupancy Trends: Confirm the sustainability of the occupancy rate improvements (88.4% for Integrated Senior Health Campuses and 85.8% for SHOP) driving revenue growth.
- ATM Offering Status: Monitor the remaining capacity ($332.1 million) and utilization of the At-The-Market (ATM) equity offering program.
- Derivative Valuation: Review the fair value changes of interest rate swaps, which resulted in a $0.75 million loss in Q1 2025 compared to a $6.4 million gain in Q1 2024.